FY2025 EPS Forecast for Lexeo Therapeutics Lifted by Analyst
Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Free Report) – Equities researchers at Chardan Capital lifted their FY2025 EPS estimates for Lexeo Therapeutics in a research report issued on Tuesday, April 8th. Chardan Capital analyst G. Livshits now forecasts that the company will post earnings of ($3.06) per share for the year, up from their prior forecast […]
Lexeo Therapeutics, Inc. (NASDAQ:LXEO – Free Report) – Equities researchers at Chardan Capital lifted their FY2025 EPS estimates for Lexeo Therapeutics in a research report issued on Tuesday, April 8th. Chardan Capital analyst G. Livshits now forecasts that the company will post earnings of ($3.06) per share for the year, up from their prior forecast […]